BD Neoflon Pro Safety Safety IV Catheter 391662Recalls & reported problems
Becton, Dickinson And Company · NEOFLON PRO SAFETY 24GX0.75IN WINGED · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00382903916627), received between Mar 29, 2019 and Sep 7, 2023 — classified as 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Backflow” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Backflow2
- Activation Problem1
- Break1
- Manufacturing, Packaging or Shipping Problem1
- Retraction Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Exposure to Body Fluids1
- Insufficient Information1
- Needle Stick/Puncture1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 7, 2023Backflow; Backflow
IT WAS REPORTED THAT WHILE USING THE BD VENFLON¿ PRO SAFETY THER WAS BLOOD BACKFLOW DURING BLOOD DRAW. THE FOLLOWING WAS RECEIVED BY THE INITIAL REPORTER: UPON INSERTION, THERE IS NO BACK FLOW WHICH MAKE THE STAFF DO LITTLE MANIPULATION WHICH CAUSES BULGING OF THE VEIN AND SO, CAUSING MULTIPLE PRICKS FOR PATIENTS. THE NEEDLE IS LONG, THE HUB IS HEAVY. IN NICU, WE ARE COLLECTING LABORATORY SAMPLES DURING FIRST IV CANNULA INSERTION TO AVOID MANY PRICKS. BUT WITH BD IT IS DIFFICULT TO COLLECT BLOOD SAMPLE. THE DISTANCE OF NEEDLE FROM THE HUB IS LONG, SO THE BLOOD BEING ACCUMULATED IN THE HUB IS MORE BEFORE ITS DROPS TO THE SPECIMEN COLLECTION BOTTLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17702708 ↗MalfunctionOct 18, 2022Manufacturing, Packaging or Shipping Problem; Activation Problem; Manufacturing, Packaging or Shipping Problem; Activation Problem
IT WAS REPORTED THAT THE BD NEOFLON PRO SAFETY CATHETER EXPERIENCED DEVICE DAMAGE WHILE STILL CONSIDERED OPERABLE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: SPRING INSIDE PIVC/FLASH CHAMBER GOT STUCK AND BLOOD SAMPLES COULD NOT BE TAKEN.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15621026 ↗InjurySep 14, 2021Retraction Problem; Retraction Problem
IT WAS REPORTED THAT NEOFLON PRO SAFETY 24GX0.75IN WINGED NEEDLE WOULD NOT RETRACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CHILD BEING CANNULATED. REGISTRAR REMOVED NEEDLE FROM SAFETY CANNULA. NEEDLE WAS DIFFICULT TO REMOVE AND THE SAFETY CATCH FAILED TO DEPLOY LEAVING NEEDLE EXPOSED AND CAUSING DOCTOR TO SUSTAIN NEEDLE STICK INJURY.
Patient problems: Insufficient Information; Needle Stick/Puncture
MAUDE report 12467880 ↗MalfunctionDec 3, 2019Break; Break
IT WAS REPORTED THAT THE BD NEOFLON PRO SAFETY IV CATHETER WITH WINGS 24 GA 0.75 IN EXPERIENCED CATHETER TIP DAMAGE/DEFORMATION DURING USE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: FOR THE ADMINISTRATION OF CHEMOTHERAPY THERAPY, WE PROCEED WITH THE POSITIONING OF A PERIPHERAL VENOUS CATHETER. WE PROCEED WITH THE DETACHMENT PROCEDURE (MINIMUM RETRACTION OF THE SPINDLE AND ADVANCEMENT IN THE INITIAL POSITION) AND WITH VENIPUNCTURE. GIVEN THE PRESENCE OF BLOOD IN THE REFLUX CHAMBER, THE MANDREL WAS SIMULTANEOUSLY RETRACTED AND THE CATHETER WAS ADVANCED. DURING THIS PROCEDURE IT WAS POINTED OUT THAT THE CATHETER WAS PARTIALLY CUT ABOUT ONE CENTIMETER FROM THE TIP. THE DEVICE WAS THEN REMOVED AND PLACED AGAIN.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9405288 ↗InjuryMar 29, 2019Backflow
IT WAS REPORTED THAT THERE HAVE BEEN ONGOING ISSUES WITH THE BACK FLOW OF BD¿ NEOFLON PRO SAFETY 24GX0.75IN WINGED ONCE THE SAFETY DEVICE IS REMOVED. HEALTHCARE WORKER EXPOSED TO BLOOD. NO MEDICAL INTERVENTION WAS REPORTED.
Patient problems: Exposure to Body Fluids
MAUDE report 8464993 ↗
Other Catheter, intravascular, therapeutic, short-term less than 30 days devices
- BD Insyte Autoguard 382523Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days660 reports
- BD Insyte Autoguard 382533Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls527 reports
- BD PosiFlush 306546Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 death608 reports
- BD Insyte Autoguard Shielded IV Catheter 381823Becton, Dickinson And Company · Catheter, intravascular, therapeutic, short-term less than 30 days582 reports
- BD Insyte Autoguard 381423Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 recall528 reports
- BD Insyte Autoguard 382544Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 recall437 reports
- BD Nexiva, BD Q-Syte 383536Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls374 reports
- BD PosiFlush 306547Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls1 death331 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page